AU7083596A - Novel substituted azacyclic or azabicyclic compounds - Google Patents
Novel substituted azacyclic or azabicyclic compoundsInfo
- Publication number
- AU7083596A AU7083596A AU70835/96A AU7083596A AU7083596A AU 7083596 A AU7083596 A AU 7083596A AU 70835/96 A AU70835/96 A AU 70835/96A AU 7083596 A AU7083596 A AU 7083596A AU 7083596 A AU7083596 A AU 7083596A
- Authority
- AU
- Australia
- Prior art keywords
- novel substituted
- azabicyclic compounds
- substituted azacyclic
- azacyclic
- azabicyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK106395 | 1995-09-22 | ||
| DK1063/95 | 1995-09-22 | ||
| DK116695 | 1995-10-16 | ||
| DK1166/95 | 1995-10-16 | ||
| PCT/DK1996/000401 WO1997011072A1 (en) | 1995-09-22 | 1996-09-20 | Novel substituted azacyclic or azabicyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7083596A true AU7083596A (en) | 1997-04-09 |
Family
ID=26065156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU70835/96A Abandoned AU7083596A (en) | 1995-09-22 | 1996-09-20 | Novel substituted azacyclic or azabicyclic compounds |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0853621A1 (en) |
| JP (1) | JPH11512443A (en) |
| AU (1) | AU7083596A (en) |
| WO (1) | WO1997011072A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4394897A (en) * | 1996-10-30 | 1998-05-22 | Pfizer Inc. | Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and the ir use in addiction therapy |
| CA2289570C (en) * | 1997-05-30 | 2007-04-03 | Neurosearch A/S | 9-azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ach receptors |
| DK0984965T3 (en) | 1997-05-30 | 2004-09-27 | Neurosearch As | 8-azabicyclo [3.2.1] oct-2 end derivatives as cholinergic ligands at nicotine ACh receptors |
| AU736547B2 (en) | 1997-05-30 | 2001-08-02 | Neurosearch A/S | Azacyclooctane and heptane derivatives, their preparation and use in therapy |
| US6362009B1 (en) | 1997-11-21 | 2002-03-26 | Merck & Co., Inc. | Solid phase synthesis of heterocycles |
| US6632823B1 (en) * | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
| UA66825C2 (en) * | 1997-12-31 | 2004-06-15 | Пфайзер Продактс Інк. | Azapolycyclic compounds condensed with aryl |
| ATE240331T1 (en) * | 1998-04-02 | 2003-05-15 | Targacept Inc | AZATRICYCLO(3.3.1.1) DECANDERIVATES AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
| US6432975B1 (en) | 1998-12-11 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US6953855B2 (en) | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| FR2790474B1 (en) * | 1999-03-05 | 2001-04-06 | Synthelabo | PYRIDOPYRANOAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| SE9903760D0 (en) * | 1999-10-18 | 1999-10-18 | Astra Ab | New compounds |
| US6890935B2 (en) | 1999-11-01 | 2005-05-10 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US6852721B2 (en) | 2000-05-25 | 2005-02-08 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US6579878B1 (en) | 2000-07-07 | 2003-06-17 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US6624167B1 (en) | 2000-08-04 | 2003-09-23 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| PE20060437A1 (en) | 2004-06-18 | 2006-06-08 | Novartis Ag | AZA-BICYCLONONE COMPOUNDS AS CHOLINERGIC LINKS OF nAChR |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| EP1802258A4 (en) | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | Biosynchronous transdermal drug delivery |
| GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
| GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| JP2010523587A (en) | 2007-04-02 | 2010-07-15 | パーキンソンズ インスティテュート | Methods and compositions for reducing the side effects of therapeutic treatments |
| SA08290475B1 (en) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2S,3R)-N-(2-((3-Pyridinyl)Methyl)-1-Azabicyclo[2.2.2]Oct-3-yl)Benzofuran-2-Carboxamide, Novel Salt forms, and Methods of Use Thereof |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| GB0913318D0 (en) | 2009-07-31 | 2009-09-02 | Univ Loughborough | Process |
| US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
| US9724340B2 (en) | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
| EP3565617A1 (en) | 2017-01-06 | 2019-11-13 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| EP3801732A4 (en) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | Drug delivery methods and systems |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3852279A (en) * | 1973-03-12 | 1974-12-03 | Squibb & Sons Inc | 7-substituted -3,3a,4,5,6,7-hexahydro-3-substituted-2h- pyrazolo (4,3-c)pyridines |
| GB8917957D0 (en) * | 1989-08-05 | 1989-09-20 | Beecham Group Plc | Novel compounds |
| JPH06239861A (en) * | 1993-02-17 | 1994-08-30 | Kanegafuchi Chem Ind Co Ltd | Bicyclic nitrogen-containing compound |
-
1996
- 1996-09-20 JP JP9512337A patent/JPH11512443A/en active Pending
- 1996-09-20 WO PCT/DK1996/000401 patent/WO1997011072A1/en not_active Application Discontinuation
- 1996-09-20 EP EP96931759A patent/EP0853621A1/en not_active Withdrawn
- 1996-09-20 AU AU70835/96A patent/AU7083596A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0853621A1 (en) | 1998-07-22 |
| WO1997011072A1 (en) | 1997-03-27 |
| JPH11512443A (en) | 1999-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7083596A (en) | Novel substituted azacyclic or azabicyclic compounds | |
| AU8375591A (en) | Azacyclic compounds | |
| AU6299396A (en) | Novel substituted azacyclic or azabicyclic compounds | |
| AU6971794A (en) | Novel compounds | |
| AU1272295A (en) | Proinsulin-like compounds | |
| AU3382595A (en) | Novel compounds | |
| AU6993596A (en) | Phthalocyanine compounds | |
| AU7055396A (en) | Organic compounds | |
| AU6993696A (en) | Phthalocyanine compounds | |
| AU6304196A (en) | Substituted cyanophenyluracils | |
| AU6993896A (en) | Phthalocyanine compounds | |
| AU6299496A (en) | Novel substituted azabicyclic compounds | |
| AU4514496A (en) | Novel compounds | |
| AU5261093A (en) | Aminoalkylphenyl compounds | |
| AU4839196A (en) | Polyazacycloalkane compounds | |
| ZA945237B (en) | Azabicyclic dericatives | |
| AU7125096A (en) | Novel substituted azacyclic or azabicyclic compounds | |
| AU4399396A (en) | Compounds | |
| AU2320895A (en) | Polyalkylpiperidine compounds | |
| AU1217797A (en) | New compounds | |
| AU6304396A (en) | Substituted carbonylaminophenyluracils | |
| AU672124B2 (en) | Composition | |
| AU7055496A (en) | Organic compounds | |
| AU6657596A (en) | Trindene compounds | |
| AU6758394A (en) | Biosensors |